Back to Search
LAWRENCE SEYMOUR, MD
MD
Emergency Medicine Physician
NPI: 1861954521Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
ME150902(FL)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells.
PMID 19461878·PLoS Pathog·2009
7-preclinical
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.
PMID 19424581·Int J Oncol·2009
3-trial
Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma.
PMID 19363466·Cancer Gene Ther·2009
7-preclinical
Electrochemical and electrogenerated chemiluminescent studies of a trinuclear complex, [((phen)2Ru(dpp))2RhCl2]5+, and its interactions with calf thymus DNA.
PMID 19358569·Anal Chem·2009
7-preclinical
Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group.
PMID 19357539·J Thorac Oncol·2009
8-other
Preclinical screening of gene therapy in human tissues.
PMID 19348049·Hum Gene Ther·2009
7-preclinical
Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition.
PMID 19272448·Cell Signal·2009
7-preclinical
Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer.
PMID 19257852·Hum Gene Ther·2009
7-preclinical
In vitro evaluation of a 'stealth' adenoviral vector for targeted gene delivery to adult mammalian neurones.
PMID 19248141·J Gene Med·2009
7-preclinical
Phase I study of cediranib in combination with oxaliplatin and infusional 5-Fluorouracil in patients with advanced colorectal cancer.
PMID 19228749·Clin Cancer Res·2009
3-trial
P-selectin dependent targeting to inflamed endothelium of recombinant P-selectin glycoprotein ligand-1 immunoglobulin chimera-coated poly[N-(2-hydroxypropyl) methacrylamide]-DNA polyplexes in vivo visualised by intravital microscopy.
PMID 19219895·J Gene Med·2009
7-preclinical
Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components.
PMID 19166885·J Control Release·2009
8-other
Stopping a trial early in oncology: for patients or for industry?
PMID 19150952·Ann Oncol·2009
8-other
Phase II trial of OGX-011 in combination with docetaxel in metastatic breast cancer.
PMID 19147778·Clin Cancer Res·2009
3-trial
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.
PMID 19131551·Blood·2009
7-preclinical
A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.
PMID 19091548·Eur J Cancer·2009
3-trial
Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer.
PMID 19047292·J Clin Oncol·2009
8-other
Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial.
PMID 19667274·J Clin Oncol·2009
8-other
Quantitative characterization of cell transduction by HSV-1 amplicons using flow cytometry and real-time PCR.
PMID 19490970·J Virol Methods·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 300 PINELLAS ST
CLEARWATER, FL 33756 - Phone
- (727) 298-6612
Quick Facts
- NPI
- 1861954521
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile